3 Undervalued Biotech Gems With 200%+ Analyst Price Targets

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

These three undervalued biotech stocks have begun garnering investor attention as their treatments show promise.

The post 3 Undervalued Biotech Gems With 200%+ Analyst Price Targets appeared first on InvestorPlace.

More From InvestorPlace

• The #1 AI Investment Might Be This Company You’ve Never Heard Of
• Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
• Legendary Investor Predicts: “Forget A.I. THIS Technology Is the Future”